Clarity Pharmaceuticals Ltd. earnings per share and revenue

CLRPF earnings per share for the last semiannual are -0.05 USD whereas the estimation was -0.05 USD which accounts for -0.68% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 3.66 M USD. Estimated earnings per share for the next semiannual are -0.04 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of CLRPF earnings per share and revenue dynamics.